<< Back
Myeloperoxidase (IDK® Myeloperoxidase) ELISA
K6631B, K6631 B, K 6631 B, 6631B, 6631 B, 6631
Article number:
K 6631B
96 Tests
Incubation time:
1 h; 1 h; 10-20 min
100 µl (Pl.), 25 µl (Ser.)
Plasma, Serum
1.9-30 ng/ml
Details (PDF)
To access these files, you need the Acrobat Reader
MPO as prognostic marker for cardiovascular diseases
MPO is part of the defense mechanism of the polymorphonuclear leukocytes against exogenic substances. Recent studies suggest a mechanistic link between myeloperoxidase, inflammation and both acute and chronic manifestations of cardiovascular diseases.
MPO is suited for the followin indications:

  • Oxidative stress

  • Risk asssessment in patients with acute coronary syndrome

Purchase Order Processing

Claudia Wandesleben / Gudrun Gutschalk
Phone: +49 6251 70190-175 /-177
Fax: +49 6251 70190-363
email: export@immundiagnostik.com


Contact Form Order Form